The HinduLean L·
U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older
Read at The Hindu →
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older
<iframe src="https://hindustansphere.com/embed/cluster/b983531c01882fc4cee6b1150daa24ad71e046b5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="U.S. FDA approves first mRNA flu shot from Moderna"></iframe>
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older